Polyradiculoneuropathy

• EMA approval · 2026-06-05
  EMA Authorised: HyQvia (human normal immunoglobulin) — Baxalta Innovations GmbH

  The EMA has authorised HyQvia (human normal immunoglobulin) from Baxalta Innovations GmbH for use in immunologic deficiency syndromes and re…

• CLINICAL_TRIALS trial_result · 2018-07-05
  Clinical Trial Update: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) [Phase 3]

  A Phase 3 study evaluating subcutaneous immunoglobulin IgPro20 for chronic inflammatory demyelinating polyneuropathy has completed and poste…